China’s WuXi AppTec Acquires US Clinical Research Service Firm Pharmapace

Login to View

Chinese pharmaceutical and medical device firm WuXi AppTec has acquired Pharmapace, Inc., a US-based clinical research services company that provides biometrics services for all phases of clinical trials, regulatory submissions, and post-marketing support, according to a statement released on Monday.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Read 2 Articles for Free with a Basic Account

Gain limited and restricted access to China Money Network.

Register Basic Account

Subscribe for an annual subscription!

Enjoy comprehensive and exclusive data you can't find elsewhere!

More Info


Subscribe and Pay Easily Online!

Already have an account or paid subscription? Log in


RELATED NEWS